GEROSCIENCE TRAINING PROGRAM IN OKLAHOMA

俄克拉荷马州老年科学培训计划

基本信息

项目摘要

ABSTRACT The etiology of aging and age-related disease is poorly understood. Over the past 3 decades, there have been impressive advances in our understanding of the critical role of aging in the development of many diseases that limit quality of life. Aging and diseases associated with age clearly result in dependence and a severe reduction in health-span; however, without a clear understanding of the interactions between aging and disease, effective therapies cannot be developed. Our training program in GeroScience was initiated in 2017 as a new approach to training the next generation of researchers to address the complex causes of aging and their interactions with age-related disease. We originally requested support for 3 pre-doctoral and 4 post-doctoral fellows for 16 faculty. Over the last 4 years, the program has leveraged this support to train a total of 8 pre- doctoral trainees and 9 post-doctoral trainees. The total number of trainees during this initial funding period will continue to expand in the -05 year of the program. It is particularly important to note that as our trainees are accepted to the T32 program, they undergo a rigorous training plan and are required to write grant applications to support their proposed research. Importantly, trainees that rotate off our T32 due to the funding of their Federal or Association sponsored awards continue to participate in, and benefit from, the overall training program that we have established. Similarly, our mentors are recertified each year and we have developed a program to train young mentors. Predoctoral Students: Of the 8 pre-doctoral students that have entered our program, seven (7) are on-track or have completed their PhD. Seventy-five percent (75%) of the pre-doctoral students (6) have written grant applications and, of those submitting applications, 100% have been funded. Importantly, these are primarily F31, R36, and AHA grants. These trainees have produced 4.12 publications to date. Post-Doctoral Fellows: Of the nine (9) post-doctoral candidates, seven (7) fellows have submitted grants thus far and, of these, 57% have received funding. The trainees average 8.91 publications to date. The vast majority of our students have won local and national awards for their presentations. Those that have graduated have found employment in both academic and pharmaceutical environments. Based on our level of success, current census and plans for continued expansion of our program, we have increased our mentoring faculty to 21 and are requesting 4 graduate and 4 post-doctoral trainee positions to continue our training in GeroScience.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Benjamin Francis Miller其他文献

Benjamin Francis Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Benjamin Francis Miller', 18)}}的其他基金

Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy
长期升高的 mTOR 活性损害废用性萎缩后老年肌肉恢复的机制
  • 批准号:
    10641855
  • 财政年份:
    2022
  • 资助金额:
    $ 49.55万
  • 项目类别:
Mechanism through which chronically elevated mTOR activity impairs aged muscle recovery after disuse atrophy
长期升高的 mTOR 活性损害废用性萎缩后老年肌肉恢复的机制
  • 批准号:
    10473096
  • 财政年份:
    2022
  • 资助金额:
    $ 49.55万
  • 项目类别:
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan
确定二甲双胍治疗对肌肉线粒体和健康寿命的背景特异性
  • 批准号:
    10462944
  • 财政年份:
    2022
  • 资助金额:
    $ 49.55万
  • 项目类别:
Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging
剖析蛋白质周转的综合机制,以防止蛋白质沉积随衰老而下降
  • 批准号:
    10706458
  • 财政年份:
    2022
  • 资助金额:
    $ 49.55万
  • 项目类别:
Dissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging
剖析蛋白质周转的综合机制,以防止蛋白质沉积随衰老而下降
  • 批准号:
    10390925
  • 财政年份:
    2022
  • 资助金额:
    $ 49.55万
  • 项目类别:
Determining the context specificity of metformin treatment on muscle mitochondria and healthspan
确定二甲双胍治疗对肌肉线粒体和健康寿命的背景特异性
  • 批准号:
    10596174
  • 财政年份:
    2022
  • 资助金额:
    $ 49.55万
  • 项目类别:
DNA turnover in myofibers is an unrecognized mechanism for maintaining skeletal muscle health
肌纤维中的 DNA 更新是维持骨骼肌健康的一种未被认识的机制
  • 批准号:
    10239252
  • 财政年份:
    2020
  • 资助金额:
    $ 49.55万
  • 项目类别:
A novel approach to understand a mechanism of proteostatic decline with aging
一种理解衰老过程中蛋白质抑制下降机制的新方法
  • 批准号:
    10229298
  • 财政年份:
    2020
  • 资助金额:
    $ 49.55万
  • 项目类别:
DNA turnover in myofibers is an unrecognized mechanism for maintaining skeletal muscle health
肌纤维中的 DNA 更新是维持骨骼肌健康的一种未被认识的机制
  • 批准号:
    10065144
  • 财政年份:
    2020
  • 资助金额:
    $ 49.55万
  • 项目类别:
Does insulin sensitivity impact the potential of metformin to slow aging?
胰岛素敏感性是否会影响二甲双胍延缓衰老的潜力?
  • 批准号:
    10579890
  • 财政年份:
    2019
  • 资助金额:
    $ 49.55万
  • 项目类别:

相似海外基金

Collaborative Research: Conference: Texas-Oklahoma Representations and Automorphic forms (TORA)
合作研究:会议:德克萨斯州-俄克拉荷马州表示和自同构形式 (TORA)
  • 批准号:
    2347096
  • 财政年份:
    2024
  • 资助金额:
    $ 49.55万
  • 项目类别:
    Standard Grant
ART: Intensifying Translation of Research in Oklahoma (InTRO)
艺术:俄克拉荷马州研究的强化转化(InTRO)
  • 批准号:
    2331409
  • 财政年份:
    2024
  • 资助金额:
    $ 49.55万
  • 项目类别:
    Cooperative Agreement
Collaborative Research: Conference: Texas-Oklahoma Representations and Automorphic forms (TORA)
合作研究:会议:德克萨斯州-俄克拉荷马州表示和自同构形式 (TORA)
  • 批准号:
    2347095
  • 财政年份:
    2024
  • 资助金额:
    $ 49.55万
  • 项目类别:
    Standard Grant
Collaborative Research: Conference: Texas-Oklahoma Representations and Automorphic forms (TORA)
合作研究:会议:德克萨斯州-俄克拉荷马州表示和自同构形式 (TORA)
  • 批准号:
    2347097
  • 财政年份:
    2024
  • 资助金额:
    $ 49.55万
  • 项目类别:
    Standard Grant
IHBEM: Using socioeconomic, behavioral and environmental data to understand disease dynamics: exploring COVID-19 outcomes in Oklahoma
IHBEM:利用社会经济、行为和环境数据了解疾病动态:探索俄克拉荷马州的 COVID-19 结果
  • 批准号:
    2327844
  • 财政年份:
    2024
  • 资助金额:
    $ 49.55万
  • 项目类别:
    Continuing Grant
Equipment: Acquisition of the IRIS instruments FullWaver device for monitoring active landslides in Oklahoma
设备:购买 IRIS 仪器 FullWaver 设备,用于监测俄克拉荷马州活跃的山体滑坡
  • 批准号:
    2302845
  • 财政年份:
    2023
  • 资助金额:
    $ 49.55万
  • 项目类别:
    Standard Grant
Oklahoma C. difficile U19 Administrative Core
俄克拉荷马州艰难梭菌 U19 管理核心
  • 批准号:
    10625173
  • 财政年份:
    2023
  • 资助金额:
    $ 49.55万
  • 项目类别:
Oklahoma Center for Respiratory and Infectious Diseases
俄克拉荷马州呼吸和传染病中心
  • 批准号:
    10628212
  • 财政年份:
    2023
  • 资助金额:
    $ 49.55万
  • 项目类别:
Post-Baccalaureate Research and Education Program (PREP) for Oklahoma
俄克拉荷马州学士后研究与教育计划 (PREP)
  • 批准号:
    10556953
  • 财政年份:
    2023
  • 资助金额:
    $ 49.55万
  • 项目类别:
Expanding Excellence in Developmental Biology in Oklahoma
扩大俄克拉荷马州发育生物学的卓越水平
  • 批准号:
    10629614
  • 财政年份:
    2023
  • 资助金额:
    $ 49.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了